In This Article:
- By insider
CEO of Biomarin Pharmaceutical Inc (30-Year Financial, Insider Trades) Jean Jacques Bienaime (insider trades) sold 16,667 shares of BMRN on 01/29/2021 at an average price of $82.79 a share. The total sale was $1.4 million.
Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions. Biomarin Pharmaceutical Inc has a market cap of $15.07 billion; its shares were traded at around $83.000000 with a P/E ratio of 18.99 and P/S ratio of 8.32. GuruFocus has detected 2 severe warning signs with Biomarin Pharmaceutical Inc. .
CEO Recent Trades:
-
CEO Jean Jacques Bienaime sold 16,667 shares of BMRN stock on 01/29/2021 at the average price of $82.79. The price of the stock has increased by 0.25% since.
-
CEO Jean Jacques Bienaime sold 8,333 shares of BMRN stock on 01/27/2021 at the average price of $85.49. The price of the stock has decreased by 2.91% since.
For the complete insider trading history of BMRN, click here
.This article first appeared on GuruFocus.